Introduction
Tumours of the central nervous system (CNS) and neurodegenerative diseases often cause severe disablement and premature death. Novel approaches to the treatment of such conditions, for which no curative therapy is available, are thus urgently needed. Current procedures for the delivery of therapeutic genes to the CNS predominantly employ direct injection. Neurotropic viral vectors based on Herpes simplex virus, which is taken up selectively by the nerve termini and is transferred to the cell nucleus by retrograde transport, are in development. [1] [2] [3] Adenoviral vectors have also been shown to reach the CNS after intramuscular application, 4 and recently adenovirus-mediated delivery of the neurotrophin-3 gene into 'progressive motor neuron disease' mice was reported to result in sustained high-level expression of the transgene leading to an increased lifespan and improved neuromuscular function of these mice. 5 However, as much as 99% of transgene expression was found in the injected muscles, highlighting the need for further studies on targeted gene delivery to motor neurons. Tetanus toxin (TeNT), the neurotoxin produced by Clostridium tetani, is known to enter the CNS more readily than any other foreign protein investigated so far. When applied intramuscularly TeNT binds to presynaptic motor neuron terminals, is rapidly internalised by endocytosis and reaches the cell body by retrograde axonal transport. 6, 7 The toxin then undergoes trans-synaptic spread to other cells of the central nervous system, 8 where it inhibits presynaptic neurotransmitter release. 9 TeNT contains three structural and functional domains. The L chain is responsible for the intracellular toxicity, 9 whereas the H chain contains the cell binding domain, H C , and putative endosome disruption activities. 10 Purified or recombinant H C fragment of TeNT binds to neurons and undergoes retrograde neuronal transport without any of the toxicity that is associated with the entire toxin molecule. [11] [12] [13] Enzymes such as horse radish peroxidase (HRP), superoxide dismutase (SOD-1), ␤-N-acetylhexosaminidase A and ␤-galactosidase conjugated with H C [14] [15] [16] [17] [18] have been used to demonstrate neuronal targeting and uptake of hybrid proteins both in vitro and in vivo. Administration of such conjugates in vivo resulted in delivery of both the H C fragment and the associated protein to the brain stem, the motor neurons of the spinal cord and to a lesser extent to the dorsal root ganglia. We have shown that the H C fragment coupled to poly-(L)-lysine mediates neuron-specific gene delivery to cell lines in vitro. 19 However, our attempts to apply the conjugate-DNA complexes in vivo, have so far been unsuccessful, due in particular, to the formation of large aggregates when DNA concentrations required for in vivo studies are approached.
As adenoviral vectors still represent the most efficient gene delivery vehicles available and retargeting of these vectors by different methods has been reported, [20] [21] [22] [23] [24] [25] [26] [27] we chose to continue our studies by retargeting adenovirus with both H C -polylysine conjugates and the Fab fragment of a neutralising anti-knob antibody covalently bound to H C . The latter approach, which is hypothesised to replace the natural binding of adenoviral vectors to the coxsackievirus and adenovirus receptor (CAR) by binding to a new target, 27 resulted in vectors capable of mediating selective gene transfer to neurons both in vitro and in vivo.
Results
Tetanus toxin H C fragment-polylysine conjugates enhance adenoviral infection of primary neuronal cells to a larger extent than polylysine alone Previously we reported the use of H C -polylysine conjugates for selective gene transfer into neuronal cells. 19 However, these constructs did not enhance gene delivery into either non-dividing primary neuronal cells or in vivo. As adenoviral vectors are known to infect neurons both in vitro and in vivo, we hypothesised that electrostatic binding of the H C -polylysine conjugates to adenovirus may allow its targeting to neuronal cells. This simple combination approach was tested on clumps of rat dorsal root ganglion cells that represent non-dividing and extensively differentiated primary neuronal cells, exhibiting well-developed cell bodies, neurites and growth cones. The addition of unmodified polylysine to AdRSV␤gal alone resulted in a marked increase in the proportion of cells displaying nuclear localised ␤-galactosidase activity. However, complexing of AdRSV␤gal with the H C -polylysine conjugate yielded not only intense nuclear staining of almost all cells of the clump, but also strong cytoplasmic ␤-galactosidase staining along the growing dendrites (Figure 1 a-c) . The abundance of cytoplasmic activity of the nuclear targeted enzyme indicates a very high level of transgene expression, probably caused by a high multiplicity of infection of individual cells.
However, because of the increase in non-targeted infection by polylysine, as well as the inherent instability and tendency of such complexes to form large aggregates, the potential for their successful utilisation in vivo appeared to be very limited. We therefore decided to investigate further the suitability of the tetanus toxin H C fragment for retargeting of adenoviral vectors by employing a modified Fab fragment from a neutralising anti-knob antibody (1D6.14) to mediate attachment of H C to adenovirus.
Generation and characterisation of H C :1D6.14Fab conjugates Using the cross-linking reagent SPDP a range of H C :1D6.14Fab conjugates with different molecular weights was obtained, purified by chromatography and collected in two main fractions: a high molecular weight fraction, containing conjugates with molecular weights above 200 kDa, and a low molecular weight fraction (majority of the conjugates Ͻ200 kDa).
Following separation in a polyacrylamide gel, the two conjugate fractions were transferred together with a free H C control to a Hybond C filter and were probed separately with either a polyclonal antibody raised against recombinant H C or an anti-mouse antibody (Figure 2a) . Lane 3 shows the 50 kDa-band of free H C detected with the anti-H C antibody. No such band was detectable in the corresponding lane 6 probed with anti-mouse antibody. Lanes 2 and 5, which contain the low molecular weight conjugate fraction and were probed with anti-H C antibody and anti-mouse antibody, respectively, show the predicted 100 kDa band of H C :1D6.14Fab conjugate consisting of a single Fab fragment and a single H C molecule. Both lanes also show 150 kDa, 200 kDa and 250 kDa bands which represent increasing numbers of either H C or 1D6.14Fab molecules within the conjugate. Although the resolution of the gel is limited to approximately 250 kDa, the presence of some larger conjugates is evident in the stacking gel (lanes 2 and 5). Lanes 1 and 4 containing the high molecular weight fraction show conjugates with sizes above 200 kDa, the approximate molecular weight cut-off of this particular FPLC fraction. To demonstrate binding to adenoviral fiber knob protein, the high and low molecular weight H C :1D6.14Fab conjugates were analysed further following separation of duplicate samples on a non-reducing SDS polyacrylamide gel together with free H C and 1D6.14Fab as controls. Samples were either stained with Gelcode Blue to detect total protein (Figure 2b ) or transferred to a PVDF membrane ( Figure 2c ) and probed with recombinant adenovirus type 5 fiber knob protein. The adenoviral protein was found to bind to both high and low molecular weight H C :1D6.14Fab conjugates and to free 1D6.14Fab, but not to free H C .
Re-targeting of adenovirus with tetanus toxin H C fragment results in neuron-specific gene delivery To investigate the suitability of the two H C :1D6.14Fab conjugate fractions for retargeting of adenovirus, three different adenoviral vectors were complexed with the conjugates. Their infectivity was compared with that of the respective unmodified vectors in parallel on N18RE105 cells, which display the TeNT receptor, and on HeLa, SW480 and HuTu80 cells, which do not display this receptor. reduced dramatically. Submaximal conjugate concentrations, allowing a combination of retargeting and residual infection via natural cellular adenovirus receptors, appeared to increase the percentage of infected neuronal cells slightly above that seen with unmodified adenovirus (Figure 3) . A reduced staining intensity of these N18RE105 cells was noted, indicating a lower level of ß-galactosidase gene expression most likely due to a lower number of virus particles per cell (data not shown).
To quantify the levels of gene expression obtained by unmodified and retargeted viruses more accurately, an adenoviral vector carrying a luciferase reporter gene was used in further experiments, in which low or high molecular weight conjugates were added to the adenovirus before infection of N18RE105 or HeLa cells (Figure 4) . Addition of increasing amounts of the low molecular weight H C :1D6.14Fab conjugates led to a steady decrease of the luciferase activities in both the neuronal and nonneuronal cells. At the maximally applied amount of conjugate (0.64 g/10 8 p.f.u. of adenovirus) the level of reporter gene expression in N18RE105 cells was reduced in different experiments to between 33 and 69% of the control level obtained with unmodified adenovirus. In contrast, in HeLa cells a drop of more than two orders of magnitude was observed. A representative experiment is shown in Figure 4a , where the difference in the luciferase gene expression levels between N18RE105 and HeLa cells is 50-fold.
Similar results were obtained in analogous experiments with a third adenoviral vector carrying a human factor IX gene (data not shown).
The complementary results with the luciferase-and ␤-galactosidase-encoding vectors indicate that the low molecular weight conjugate fraction reduces adenoviral infection of both neuronal and non-neuronal cell lines. This leads to a lower number of infected cells (as shown by the ␤-galactosidase staining) and a lower multiplicity of infection per cell (as shown by the luciferase activities). In N18RE105 cells this reduction of infectivity is not reflected by a drop in the number of infected cells as it is compensated by H C -mediated targeting to neuronal cells. However, this targeting does not substitute fully for the natural adenoviral infection via CAR. Therefore the number of infectious viral particles per cell and consequently the luciferase gene expression levels are reduced.
Complexing of the luciferase-encoding vector with low concentrations of the high molecular weight conjugates resulted in more than three-fold increased luciferase activities compared with the unmodified vector following infection of N18RE105 cells. At higher concentrations of these conjugates luciferase activities dropped and stayed approximately 50% above those obtained with unmodified vector, but showed a significant difference between N18RE105 and HeLa cells only at concentrations of more than 0.16 g/10 8 p.f.u. of adenovirus (Figure 4b ). However, even at the maximally applied amount of the conjugates (0.64 g/10 8 p.f.u. of virus) this difference was only 17-fold. As this amount of either conjugate fraction gave the maximal reduction of infection of non-neuronal cells, the low molecular weight H C :1D6.14Fab conjugates appear to allow more specific gene delivery to neuronal cells than the high molecular weight conjugates.
Adenovirus retargeting by H C :1D6.14Fab conjugates was further proven in competition experiments using excessive amounts of free tetanus toxin H C fragment ( Figure 5 ). Complexing the virus with unmodified Fab resulted in nearly 99% reduction of reporter gene expression in N18RE105 cells, while addition of low molecular weight H C :1D6.14Fab conjugates restored the level of luciferase activity achieved with unmodified virus almost completely. However, when the retargeting was performed in the presence of a 400-fold excess of free H C , the luciferase activity was reduced by more than one order of magnitude. Thus, free H C prevents the binding of H C :1D6.14Fab-adenovirus complexes to the target cells demonstrating redirection of adenoviral infection via the target receptor. In a series of experiments with vector-cell contact times ranging from 1 to 4 h, followed by incubation in vector-free medium, the competition effect was seen most clearly when the retargeted vector was left with the cells for only 1 h (data not shown). This is not surprising as free tetanus toxin H C fragment would be expected to be internalised rapidly after binding to the tetanus toxin receptor.
Intramuscular injection of adenovirus retargeted by H C :1D6.14Fab allows selective gene delivery into neurons The low molecular weight conjugates, shown to be the more effective of the two conjugate fractions, were then tested in vivo. Complexes of ␤-galactosidase-encoding adenoviral vector and low molecular weight H C :1D6.14Fab conjugates were injected into the tongues of five mice, and gene expression was visualised both at the injection site and in the hypoglossal nucleus within the brainstem, which is reached by the virus after infection of peripheral nerve endings and retrograde axonal transport. Following injection of 8 × 10 8 p.f.u. of retargeted AdRSV␤gal, similar numbers of stained motor neurons were found in the hypoglossal nucleus compared with the control group treated with unmodified adenovirus (n = 5); (6.7% versus 7.1%; Figure 6a and b) . Examination of the injection site, however, revealed a markedly reduced number of infected muscle and connective tissue cells in the tongues of those mice which had received the retargeted vector (Figure 6c and d) .
The staining of neurons was not homogeneously distributed throughout the hypoglossal nucleus: some regions had more positive neurons than others. The intensity of X-gal reactivity also varied from very intense to sparse, punctate deposits on the inside of the nuclear membrane. No pathological changes were observed in the hypoglossal nucleus, either of the neurons themselves 
u. of either unmodified AdRSV␤gal or AdRSV␤gal complexed with 10 g of low molecular weight H C :1D6.14Fab conjugates in phosphate-buffered saline were injected into the tongues of B6D2F1 mice using a Hamilton syringe. Four days later the animals were killed with an overdose of anaesthetics and perfused transcardially with paraformaldehyde. Tongue and brain stem were removed and stained by X-gal histochemistry before being embedded in paraffin wax. Serial sections of brain stem and tongue were cut and counter-stained with 0.1% neutral red. Sections from hypoglossal nucleus and tongue which are representative for the group of mice (n = 5) treated with the unmodified vector (a, hypoglossal nucleus; c, tongue) or the group treated with the retargeted vector (n = 5) respectively (b, hypoglossal nucleus; d, tongue) are shown in 300-fold final magnification. The tongue sections revealed a marked difference in the number of infected muscle and connective tissue cells, but also a different extent of infiltration by inflammatory cells (cells containing a small circular, darkly stained nucleus and little cytoplasm, which are scattered around blood vessels and between muscle fibers). Tongue sections from a control experiment, in which B6D2F1 mice were either injected with unmodified AdRSV␤gal (e) or the same amount of AdRSV␤gal mixed with 5 g of H C (f) showed no difference in the number of infected cells.
or of the surrounding glial cells. However, a stronger infiltration of the tongue by inflammatory cells was noted in all animals which had obtained the retargeted virus. To verify that the decreased tongue infection was due to blocked uptake and not to death of infected cells or some cytokine-mediated alteration in expression of the LacZ gene, we compared the tongues of mice injected with unmodified AdRSV␤gal (Figure 6e ) or AdRSV␤gal mixed with 5 g of free H C (Figure 6f ) and did not observe any significant difference in the numbers of stained cells between the two groups, although the inflammatory reactions were more prominent in the latter.
Discussion
In this study we have demonstrated that adenoviral vectors retargeted by the H C fragment of tetanus toxin maintain their ability to infect neuronal cells, whereas infection of non-neuronal cells is decreased dramatically both in vitro and in vivo. Competition experiments in vitro proved the specificity of this retargeting. We have also
shown that H C -polylysine conjugates enhance adenoviral infection of primary neuronal cells to a greater extent than polylysine alone. While the enhancement by polylysine on its own is known to be due to unspecific mechanisms, the most likely explanation for the additive effect of the H C -polylysine conjugates is that unmodified adenovirus receptors and tetanus toxin receptors are used simultaneously for vector internalisation into neuronal cells.
Neither the H C -polylysine conjugates nor the H C :1D6.14Fab conjugates used in this study are ideal targeting moieties, but represent first generation constructs to prove the principle suitability of tetanus toxin H C fragment for vector retargeting to neuronal cells. H C -polylysine conjugates are unstable and tend to form aggregates of large size. The antibody fragments linked with H C via disulphide bridges are more stable conjugates, however, their chemical structure cannot be defined accurately. Both H C :1D6.14Fab conjugate fractions were found to be mixtures of heterogeneous molecules, consisting of ligand and Fab at presumably various ratios, although Western blot analysis confirmed that a relatively high proportion of the low molecular weight conjugates contained a single Fab fragment bound to a single H C molecule. As each high molecular weight conjugate is likely to contain many Fab molecules, which may allow binding of more adenovial particles per conjugate, the observed difference in the targeting properties of the two conjugate fractions may be partially due to aggregation phenomena similar to those seen with polylysine-containing conjugates. However, as the difference between infection of neuronal and non-neuronal cells after complexing with the low molecular weight conjugates was much greater than that obtained with high molecular weight conjugates, the low molecular weight conjugate fraction is clearly more suitable for further studies.
To block the fiber knob-mediated binding of AdRSV␤gal maximally, 2 g of the low molecular weight conjugates per 10 8 p.f.u. of adenovirus were required, which is three-fold more than needed for the luciferaseencoding vector and the four-fold amount of that used by others. 21 As H C and 1D6.14Fab were conjugated using SPDP, which links the components randomly, the affinity of the binding of different conjugate molecules to the adenovirus fibre knob is likely to vary depending on the way in which each Fab molecule is presented and on the number of H C and Fab molecules present in each conjugate molecule. This, in combination with potential variations in the activity of different adenoviral preparations (eg a higher proportion of noninfectious virus particles in the AdRSV␤gal preparation), makes it difficult to draw meaningful conclusions from the amount of conjugate required for the maximum retargeting effect. The aspect of Fab presentation within the conjugate could be improved by using SH-groups which can be produced by reduction of a Fab 2 -molecule generated by pepsin digestion of the 1D6.14 antibody, to provide more control over the link between the Fab and H C . However, for practical reasons this proved not to be an optimal means of conjugation.
The inability of adenoviral vectors retargeted by H C :1D6.14Fab conjugates to infect N18RE105 cells or neurons in vivo more efficiently than untargeted virus indicates that there are sufficient adenovirus receptors on these cells allowing efficient adenoviral infection. Due to the random way in which the tetanus toxin H C fragment is linked with the 1D6.14Fab (as discussed above) it is likely to be presented often suboptimally on the adenovirus, which will lead to hampered binding to tetanus toxin receptors on NI8RE105 cells or neurons in vivo.
When applied intramuscularly into the tongues of mice, complexing with low molecular weight H C :1D6.14Fab conjugates increased the neuron/tongue ratio of adenoviral infection markedly, albeit only by reduction of non-specific infection. Retargeted viruses which do not find an appropriate receptor may be cleared relatively quickly by the large number of inflammatory cells observed in the tongues of treated mice. A relatively slower uptake of the retargeted virus into neurons may have contributed additionally to this result.
Further studies will investigate whether adenoviral vectors retargeted by tetanus toxin H C reach spinal motor neurons after intraperitoneal application or administration into the Musculus tibialis anterior and whether the retargeted virus can also be transported to dorsal root ganglia.
The clinical applicability of vector targeting by tetanus toxin H C fragment may depend on whether and when a vaccination against tetanus has been given. As this vaccination is normally administered early in life, our retargeting approach may be feasible only for the treatment of neonates and very young infants, who have not yet been vaccinated, and for adults who have already lost the protective immunity. In further studies on animals we will investigate the effects of such vaccination on the subsequent application of adenoviral vectors re-targeted by H C to determine whether the vaccination really represents an obstacle to our approach. Some inherited disorders including those which cause irreversible neuron damage and increased mortality perinatally may require treatment in utero. 28, 29 A higher proportion of neurons may be accessible, and perhaps even more specifically infected, if targeted gene therapy vectors were applied to the developing neuronal system of a fetus. Thus, vectors retargeted by the H C fragment of tetanus toxin may prove useful for gene therapy of inherited diseases, eg spinal muscular atrophy. The use of neuron-specific promoters may allow long-term transgene expression in neurons even for adenoviral vectors. 30 However, the new generation of helper-dependent adenoviral vectors 31 may represent the most suitable vector for that purpose. Another area of application could be the targeted delivery of adenoviral vectors to tumours of the nervous system, in combination with a strategy allowing the selective elimination of dividing cells, eg thymidine kinase/ganciclovir treatment.
Materials and methods
Cells and viruses N8RE105 cells from a neuroblastoma × glioma mouse/rat hybrid cell line displaying the TeNT receptor 32 were obtained from Dr PS Fishman (University of Maryland, Baltimore, MD, USA) and cultured in DMEM supplemented with 10% fetal calf serum (FCS), hypoxanthine, aminopterin and thymidine (HAT medium supplement, Sigma, Poole, UK) and sodium pyruvate (1 mm). Control cell lines used were SW480 (colon adenocarcinoma), HeLa (cervix adenocarcinoma) and HuTu80 (duodenum adenocarcinoma), all maintained in DMEM containing 10% FCS. Dorsal root ganglion cells, kindly provided by Dr C Shaw (King's College London, UK), were obtained from neonatal rats, grown in tissue culture plates coated with polylysine and laminin and allowed to differentiate for 7 to 14 days following the protocols described by Kleitman et al. 33 E1/E3-deleted adenoviral vectors AdRSV␤gal, AdTG8509 and AdTG9397 containing a nuclear targeting bacterial ␤-galactosidase reporter gene, a luciferase reporter gene and the human clotting factor IX gene respectively, were obtained from Transgene (Strasbourg, France) and prepared in our laboratory as described previously. 34, 35 Virus concentrations were determined by plaque assays on 293 cells. Each vector batch was tested for the presence of helper virus according to Graham et al. 34, 36 No passage of virus was detected after exposing 293 cells to supernatants of infected HeLa cells.
Formation of H C :poly(K) and H C :1D6.14Fab conjugates H C :poly(K) conjugates were made and purified as described previously. 19 H C :1D6.14Fab conjugates were generated by linking recombinant H C protein produced in yeast, 37 with the Fab fragment of a blocking monoclonal antibody (1D6.14) raised against adenovirus serotype 5 fiber knob. 21 For this conjugation, the H C and the Fab fragment were both modified separately with the cross-linking reagent N-succinimidyl-3-[2-pyridyldithio]propionate (SPDP; Pierce, Rockford, IL, USA) dissolved in DMSO at a molar ratio of 1:5 (protein/SDPD) at room temperature. After removal of unbound SPDP by filtration, the Fab-bound SPDP was activated by reduction with dithiothreitol (DTT) at pH 4.5 for 5 min. The DTT was then removed by gel filtration and the pH was adjusted to 7.4. Activated Fab-SPDP and H C -SPDP were mixed together at a molar ratio of 1:1 and allowed to react overnight at room temperature. The H C :Fab conjugates were loaded on to a preparation grade superose-12 column equilibrated with borate buffer, pH 7.4, and separated using an FPLC apparatus. Avoiding the highest molecular weight conjugates both a high and a low molecular weight fraction were collected and concentrated with 50 kDa cut-off Centricon ultrafiltration devices (Centricon; Millipore, Watford, UK). The conjugates were analysed by polyacrylamide gel electrophoresis and Western blotting using recombinant adenovirus fibre knob and a polyclonal antibody raised against recombinant H C , respectively.
SDS polyacrylamide gel electrophoresis and Western blotting
Non-reducing SDS-6% polyacrylamide gels were used to analyse the H C :1D6.14Fab conjugate fractions according to a standard protocol. The proteins were transferred to a Hybond C membrane (Amersham, Little Chalfont, UK) using a semi-dry blotter (BioRad, Hercules, CA, USA). The membrane was treated with a blocking buffer containing 3% dried milk and 0.05% Tween 20 in PBS, and its two duplicate halves were separated. One half was probed with a 1:2000 diluted anti-mouse antibody-horse radish peroxidase conjugate (Dako, High Wycombe, UK), while the second half was probed with a 1:2000 diluted rabbit anti-H C antibody, followed by incubation with 1:2000 diluted anti-rabbit antiserum conjugated with horse radish peroxidase (Dako). Bands were visualised using an ECL kit (Amersham) following the instructions provided by the manufacturer.
To demonstrate binding of the conjugates to the adenoviral fibre knob protein, high and low molecular weight conjugate samples were separated on a non-denaturing 10% polyacrylamide gel. Duplicate halves of the gel were stained with Gelcode Blue Stain (Pierce) or transferred to a PVDF membrane, which was then probed with recombinant adenovirus type 5 fibre knob containing a tag of six histidine residues, followed by exposure to Nickelalkaline phosphatase. Knob-binding activity was visualised using an alkaline phosphatase detection kit (BioRad). Clumps of differentiated rat dorsal root ganglion cells were infected with 10 7 p.f.u. of unmodified AdRSV␤gal or complexes of AdRSV␤gal and 0.5 g of either unmodified polylysine or H C -polylysine conjugate, formed in DMEM containing 10% FCS. The experiment was performed in duplicate wells. Following exposure to the virus for 4 h the medium was aspirated carefully and replaced by serum-free neuronal culture medium, whereafter the incubation was continued for 44 h.
Infection assays in vitro

Animals and procedures
Sixteen B6D2F1 mice (Harlan, Oxford, UK) were used in this study. The animals were anaesthetised by intramuscular injection of 1 l/g body weight of a 1:2 (vol/vol) mixture of Rompun (xylazine, 20 mg/ml; Bayer, Bury St Edmunds, UK) and Vetalar (ketamine hydrochloride, 100 mg/ml; Parke-Davis, Gwent, UK). 8 × 10 8 p.f.u. of either unmodified AdRSV␤gal or AdRSV␤gal complexed with 10 g of low molecular weight H C :1D6.14Fab conjugates in phosphate-buffered saline, pH 7.4 (PBS) were injected into the tongues using a Hamilton 25-l syringe with a needle of 33 gauge (Hamilton, Bonaduz, Switzerland). As control, 8 × 10 8 p.f.u. of AdRSV␤gal mixed with 5 g of H C were injected. In one mouse leakage occurred which was taken into account by exclusion of this animal from the study. Four days after the injection the animals were killed with an overdose of anaesthetics and perfused transcardially with PBS, followed by 4% depolymerised paraformaldehyde in PBS. Tongue and brain stem (from around C1 to the upper vermis) were removed and allowed to fix in the same fixative for 1 h. All procedures were conducted in accordance with UK home office regulations and the Animals (Scientific Procedures) Act 1986.
Histochemistry
Cell were fixed in 2% formaldehyde/0.2% glutaraldehyde for 15 min, washed with PBS supplemented with 0.02% Nonidet P40 and analysed for nuclear bacterial ␤-galactosidase activity indicated by the characteristic blue staining in a PBS solution containing K 3 Fe(CN) 6 (5 mm), K 4 Fe(CN) 6 (5 mm), MgCl 2 (2 mm), 0.02% Nonidet P40, 0.01% sodium deoxycholate and X-gal (5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside dissolved in N,Ndimethylformamide) at a concentration of 0.8 mg/ml. The cells were stained overnight protected from light.
In each tissue a shallow incision was made on the dorso-medial surface to facilitate the penetration of the X-gal substrate solution. The tissues were incubated in this solution at 37°C for 24 h before being embedded in paraffin wax using a standard protocol and an automated tissue processor. Serial 10-m sections of the brainstem and 4 m sections of the tongue were cut with a microtome, mounted on glass slides and counterstained with 0.1% neutral red before being dehydrated, cleared and mounted. Every fifth section through the hypoglossal nucleus was examined at 300-fold magnification. Hypoglossal motor neurons were identified from their position and distinctive morphology, and all those displaying a nucleus were counted (on average 600 neurons per animal). The number of cells showing the intense blue Xgal staining in the nucleus is expressed as percentage of total nuclei counted.
